Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • EMR vs MRNA✓SelectedUSD · MRNAEMR vs MRNA performance historyLatest closeAs of+1.79%11/18
Stock and ETF performance explorer

EMR vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+91.9%
MRNA return
+156.2%
Excess return
-64.4%
Maximum drawdown
-29.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+1.8%-4.8%+6.6%+2.0%
7D-2.7%-20.9%+18.2%-1.8%
30D+1.3%-13.3%+14.5%+1.7%
3M+3.0%+212.6%-209.5%-4.1%
6M+23.4%+309.0%-285.7%+9.5%
YTD+23.9%+567.3%-543.4%+2.3%
1Y+29.7%+689.7%-660.0%+4.5%
All+91.9%+156.2%-64.4%+63.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling